Modera Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Modera Wealth Management's VRTX Position: Q3 2026 in Review
Modera Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q3 2026, selling an estimated $112K and leaving 19,815 shares worth $10.4M. The position accounts for 0.11% of the portfolio, ranked #125.
Modera Wealth Management first reported a position in VRTX in Q2 2023 and has held it in 14 quarters since. The position peaked at $11.6M in Q2 2024. 700 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Modera Wealth Management held 19,815 shares of Vertex Pharmaceuticals worth $10.4M as of Q3 2026.
- Modera Wealth Management sold 218 Vertex Pharmaceuticals shares in Q3 2026, an estimated $112K.
- Vertex Pharmaceuticals made up 0.11% of Modera Wealth Management's portfolio in Q3 2026, its #125 holding.
- Modera Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
- Modera Wealth Management's Vertex Pharmaceuticals position peaked at $11.6M in Q2 2024.
- 700 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Modera Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.